Skip to main content

Table 4 Five- and ten-year overall survival and relapse-free survival according to co-expression patterns of nuclear FAM83H and nuclear ZNF16

From: Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma

Co-expression pattern of nFAM83H and nZNF16

No.

5y-OS (%)

10y-OS (%)

5y-RFS (%)

10y-RFS (%)

Co-expression Model 1

 nFAM83H−/nZNF16-

32

78

73

75

70

 nFAM83H−/nZNF16+

24

38

25

38

25

 nFAM83H+/nZNF16-

13

31

31

31

31

 nFAM83H+/nZNF16+

36

14

8

11

8

Co-expression Model 2

 nFAM83H−/nZNF16-

32

78

73

75

70

 nFAM83H−/nZNF16+, nFAM83H+/nZNF16-, or nFAM83H+/nZNF16+

73

25

17

23

17

  1. Abbreviations: nFAM83H nuclear expression of FAM83H, nZNF16 nuclear expression of ZNF16, 5y-OS overall survival rate at 5 years, 10y-OS overall survival rate at 10 years, 5y-RFS; relapse-free survival rate at 5 years, 10y-RFS relapse-free survival rate at 10 years
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us